Publizoom

Unidade Local de Saúde Santa Maria, E.P.E.

1649 Lisboa

Open calls for tenders
0
Awarded contracts
200
Published notices
200

Its contracts coming to an end

Planned endContractCurrent holderAmount
7 November 2026
re-tender around October 2026		 Consulta Prévia n.º Consulta Prévia n.º 262Y000039 - Aquisição de stents coronários, AQ SPMS 587/2023 para o do ano 2026 framework agreement Medtronic Portugal Lda
1 bid received		 €250,852
20 November 2026
re-tender around October 2026		 2024/0961 - Epcoritamab [48 mg/0.8 ml sol inj frs] framework agreement ABBVIE, LDA
1 bid received		 €91,237
21 November 2026
re-tender around October 2026		 2024/0900 - Emtricitabina + rilpivirina + tenofovir [200 mg + 25 mg + 245 mg cáp/comp] framework agreement GILEAD SCIENCES, LDA
1 bid received		 €73,338
21 November 2026
re-tender around October 2026		 2023/0491 - Ibrutinib [140 mg cáp/comp] framework agreement JANSSEN-CILAG FARMACEUTICA LDA
1 bid received		 €234,620
21 November 2026
re-tender around October 2026		 2023/0491 - Ibrutinib [560 mg cáp/comp] framework agreement JANSSEN-CILAG FARMACEUTICA LDA
1 bid received		 €454,109
23 November 2026
re-tender around October 2026		 2023/0491 - Ruxolitinib [20 mg cáp/comp] framework agreement NOVARTIS FARMA - PROD.FARM SA
1 bid received		 €246,860
23 November 2026
re-tender around October 2026		 2024/0900 - Emtricitabina + tenofovir alafenamida [200 + 25 mg comp] framework agreement GILEAD SCIENCES, LDA
1 bid received		 €106,541
24 November 2026
re-tender around October 2026		 2023/0491 - Imunoglobulina antilinfócitos (coelho) [25 mg pó p/ conc p/a sol p/ perf frs] framework agreement SANOFI-PRODUTOS FARMACÊUTICOS,LDA
1 bid received		 €220,648
24 November 2026
re-tender around October 2026		 2023/0491 - Ponatinib [15 mg cáp/comp] framework agreement Cencora 3PL Portugal
1 bid received		 €290,358
24 November 2026
re-tender around October 2026		 2025/1746- Caplacizumab [10 mg/ 1 ml pó sol inj frs] framework agreement SANOFI-PRODUTOS FARMACÊUTICOS,LDA
1 bid received		 €475,068
27 November 2026
re-tender around October 2026		 2023/0491 - Gilteritinib [40 mg cáp/ comp] framework agreement ASTELLAS FARMA, LDA
1 bid received		 €77,810
27 November 2026
re-tender around October 2026		 2023/0491 - Canacinumab [150 mg/ml 1 ml sol inj frs] framework agreement NOVARTIS FARMA - PROD.FARM SA
1 bid received		 €154,616
27 November 2026
re-tender around October 2026		 2023/0491 - Darolutamida [300 mg cáp/comp] framework agreement BAYER PORTUGAL, LDA
1 bid received		 €101,115
27 November 2026
re-tender around October 2026		 2026/0098 - Alglucosidase alfa [50 mg f/amp] framework agreement SANOFI-PRODUTOS FARMACÊUTICOS,LDA
1 bid received		 €38,331
28 November 2026
re-tender around October 2026		 2025/1627 - Riociguat [2.5 mg cáp/comp] framework agreement MERCK SHARP & DOHME, LDA
1 bid received		 €305,401
28 November 2026
re-tender around October 2026		 2023/0671 - Letermovir [240 mg cáp/comp] framework agreement MERCK SHARP & DOHME, LDA
1 bid received		 €447,325
30 November 2026
re-tender around October 2026		 2023/0491 - Baricitinib [4 mg cáp/ comp] framework agreement LILLY PORTUGAL- PROD FARM, LDA
1 bid received		 €54,905
1 December 2026
re-tender around October 2026		 2024/0961 - Epcoritamab [48 mg/0.8 ml sol inj frs] framework agreement ABBVIE, LDA
1 bid received		 €395,361
1 December 2026
re-tender around October 2026		 2025/1589 - Dostarlimab [50 mg/ml 10 ml sol inj frs] framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA
1 bid received		 €336,635
4 December 2026
re-tender around October 2026		 2023/0671 - Belimumab [200 mg/1ml sol inj caneta] framework agreement GLAXO SMITHKLINE- PROD.FARMAC., LDA
1 bid received		 €87,692
5 December 2026
re-tender around October 2026		 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs] framework agreement ROCHE Farmacêutica Química, LDA
1 bid received		 €534,233
5 December 2026
re-tender around October 2026		 2023/0491 - Baricitinib [4 mg cáp/ comp] framework agreement LILLY PORTUGAL- PROD FARM, LDA
1 bid received		 €245,039
5 December 2026
re-tender around October 2026		 2025/1589 - Teclistamab [90 mg/ml 1,7 ml sol inj frs] framework agreement JANSSEN-CILAG FARMACEUTICA LDA
1 bid received		 €543,665
5 December 2026
re-tender around October 2026		 2023/0671 - Certolizumab pegol [200 mg/ 1 ml caneta] framework agreement UCB PHARMA-PROD.FARMACEUTICOS, LDA
1 bid received		 €315,294
5 December 2026
re-tender around October 2026		 2023/0481 - Axicabtagene ciloleucel [0.4 - 2 x10e8 células dispersão inj saco] framework agreement GILEAD SCIENCES, LDA
1 bid received		 €273,088
6 December 2026
re-tender around October 2026		 2023/0481 - Axicabtagene ciloleucel [0.4 - 2 x10e8 células dispersão inj saco] framework agreement GILEAD SCIENCES, LDA
1 bid received		 €273,088
7 December 2026
re-tender around October 2026		 2025/1746- Caplacizumab [10 mg/ 1 ml pó sol inj frs] framework agreement SANOFI-PRODUTOS FARMACÊUTICOS,LDA
1 bid received		 €51,638
7 December 2026
re-tender around October 2026		 2023/0491 - Guselcumab [100 mg/1 ml sol inj caneta] framework agreement JANSSEN-CILAG FARMACEUTICA LDA
1 bid received		 €74,214
7 December 2026
re-tender around October 2026		 2026/0006 - Leuprorrelina [45 mg pó e solv p/ sol inj seringa] framework agreement JABA RECORDATI,S.A.
1 bid received		 €62,594
8 December 2026
re-tender around October 2026		 2023/0491 - Guselcumab [100 mg/1 ml sol inj caneta] framework agreement JANSSEN-CILAG FARMACEUTICA LDA
1 bid received		 €9,895

Competition observed: 1,0 bids on average per contract (across 284 awarded contracts).

Who wins its contracts

Awarded contracts

Award notice Supplies Portuguese

2024/0900 - Doravirina [100 mg comp]

Unidade Local de Saúde Santa Maria, E.P.E. · Lisboa, Portugal

Awarded €263,479 Published on 20 October 2026

Source: TED (Publications Office of the European Union), notices above the EU thresholds.